Choon Ok Kim

512 total citations
48 papers, 376 citations indexed

About

Choon Ok Kim is a scholar working on Surgery, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Choon Ok Kim has authored 48 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Oncology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Choon Ok Kim's work include Drug Transport and Resistance Mechanisms (11 papers), Diabetes Treatment and Management (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Choon Ok Kim is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Diabetes Treatment and Management (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Choon Ok Kim collaborates with scholars based in South Korea and United States. Choon Ok Kim's co-authors include Min Soo Park, Jae‐Yong Chung, Duk‐Chul Lee, Sung Kweon Cho, Chung Mo Nam, Ji‐Won Lee, Youn Nam Kim, Joon Chang, Chin Kim and Jina Jung and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Nutrients.

In The Last Decade

Choon Ok Kim

48 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Choon Ok Kim South Korea 12 130 90 73 65 63 48 376
Eva Doleželová Czechia 16 137 1.1× 55 0.6× 109 1.5× 69 1.1× 69 1.1× 26 484
Hyewon Chung South Korea 16 64 0.5× 69 0.8× 128 1.8× 57 0.9× 73 1.2× 45 592
Jin Ah Jung South Korea 11 100 0.8× 62 0.7× 85 1.2× 65 1.0× 48 0.8× 49 409
Albert Bilos Netherlands 10 103 0.8× 144 1.6× 162 2.2× 56 0.9× 43 0.7× 14 431
Laura T. Grip United States 12 157 1.2× 81 0.9× 69 0.9× 45 0.7× 64 1.0× 18 727
Michael J. Knauer Canada 12 191 1.5× 126 1.4× 94 1.3× 101 1.6× 47 0.7× 25 603
Mengru Bai China 13 102 0.8× 36 0.4× 86 1.2× 52 0.8× 72 1.1× 23 321
Sung Kweon Cho South Korea 14 113 0.9× 148 1.6× 193 2.6× 64 1.0× 104 1.7× 31 661
Sara E. Mansell Canada 7 136 1.0× 48 0.5× 95 1.3× 59 0.9× 81 1.3× 8 366
Patrick Mayo Canada 12 60 0.5× 46 0.5× 91 1.2× 79 1.2× 61 1.0× 26 441

Countries citing papers authored by Choon Ok Kim

Since Specialization
Citations

This map shows the geographic impact of Choon Ok Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Choon Ok Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Choon Ok Kim more than expected).

Fields of papers citing papers by Choon Ok Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Choon Ok Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Choon Ok Kim. The network helps show where Choon Ok Kim may publish in the future.

Co-authorship network of co-authors of Choon Ok Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Choon Ok Kim. A scholar is included among the top collaborators of Choon Ok Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Choon Ok Kim. Choon Ok Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Choon Ok, et al.. (2024). Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study. Clinical and Translational Science. 17(10). e70032–e70032. 3 indexed citations
2.
3.
Shin, Anna, Sunyoung Cho, Young Soo Kim, et al.. (2024). Prediction of herb–drug interaction between hyperforin and sedative hypnotics (zolpidem, alprazolam, and midazolam) using physiologically-based pharmacokinetic modeling. Molecular & Cellular Toxicology. 20(2). 431–439. 1 indexed citations
4.
Kim, Choon Ok, et al.. (2023). Pharmacokinetic and pharmacodynamic drug–drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers. Clinical and Translational Science. 16(8). 1469–1478. 1 indexed citations
5.
Kim, Hee Young, et al.. (2023). Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects. Translational and Clinical Pharmacology. 31(1). 59–59. 1 indexed citations
6.
Cho, Sunyoung, Choon Ok Kim, Bong Soo, et al.. (2023). The effects of long-term cumulative HbA1c exposure on the development and onset time of dementia in the patients with type 2 diabetes mellitus: Hospital based retrospective study (2005–2021). Diabetes Research and Clinical Practice. 201. 110721–110721. 4 indexed citations
7.
Kim, Choon Ok, et al.. (2022). Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers. Drug Design Development and Therapy. Volume 16. 4301–4310. 2 indexed citations
8.
Kim, Chan‐Wha, et al.. (2018). Coagulant Effect and Tolerability of Yeast-Produced Recombinant Batroxobin in Healthy Adult Subjects. Clinical Drug Investigation. 38(9). 829–835. 5 indexed citations
9.
Kim, Choon Ok, et al.. (2018). Comparison of biosimilar filgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers. Drug Design Development and Therapy. Volume 12. 2381–2387. 1 indexed citations
10.
11.
Park, Min Soo, et al.. (2017). Comparison of Pharmacokinetics and Safety of a Fixed-dose Combination of Rosuvastatin and Ezetimibe Versus Separate Tablets in Healthy Subjects. Clinical Therapeutics. 39(9). 1799–1810. 14 indexed citations
12.
13.
Kim, Choon Ok, et al.. (2016). Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects. Drug Design Development and Therapy. Volume 10. 3763–3770. 3 indexed citations
14.
Kim, Choon Ok, et al.. (2015). Pharmacokinetic Interaction Between Amlodipine and Lobeglitazone, a Novel Peroxisome Proliferator–activated Receptor-γ Agonist, in Healthy Subjects. Clinical Therapeutics. 37(9). 1999–2006.e1. 11 indexed citations
15.
Kim, Choon Ok, et al.. (2014). Effect of Ketoconazole on Lobeglitazone Pharmacokinetics in Korean Volunteers. Clinical Therapeutics. 36(7). 1064–1071. 5 indexed citations
16.
Kim, Choon Ok, Sook Jin Seong, Do Young Kim, et al.. (2013). Influence of Hepatic Dysfunction on the Pharmacokinetics and Safety of Fimasartan. Journal of Cardiovascular Pharmacology. 62(6). 524–529. 8 indexed citations
17.
Chung, Jae‐Yong, Sung Kweon Cho, Tae Hee Kim, et al.. (2013). Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics. Pharmacogenetics and Genomics. 23(7). 365–373. 19 indexed citations
18.
Kim, Choon Ok, et al.. (2012). Influence of ABCC2, SLCO1B1, and ABCG2 Polymorphisms on the Pharmacokinetics of Olmesartan. Journal of Cardiovascular Pharmacology. 60(1). 49–54. 10 indexed citations
19.
Kim, Choon Ok, et al.. (2012). Impact of ABCC2, ABCG2 and SLCO1B1 Polymorphisms on the Pharmacokinetics of Pitavastatin in Humans. Drug Metabolism and Pharmacokinetics. 28(3). 196–202. 40 indexed citations
20.
Kim, Choon Ok, Chung Mo Nam, Duk‐Chul Lee, Joon Chang, & Ji‐Won Lee. (2011). Is abdominal obesity associated with the 2009 influenza A (H1N1) pandemic in Korean school‐aged children?. Influenza and Other Respiratory Viruses. 6(5). 313–317. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva Doleželová Breakdown of academic impact, for papers by Hyewon Chung Breakdown of academic impact, for papers by Jin Ah Jung Breakdown of academic impact, for papers by Albert Bilos Breakdown of academic impact, for papers by Laura T. Grip Breakdown of academic impact, for papers by Michael J. Knauer Breakdown of academic impact, for papers by Mengru Bai Breakdown of academic impact, for papers by Sung Kweon Cho Breakdown of academic impact, for papers by Sara E. Mansell Breakdown of academic impact, for papers by Patrick Mayo
Rankless by CCL
2026